![BE](/sites/all/themes/wivisp/images/be_logo_color.png)
Search results - 670 results
Herpes zoster in Belgium: a new solution to an old problem
clinical trials that has since been confirmed in real-world effectiveness studies. In clinical trials, protection was sustained for at least 10 years after vaccination. As of 1 November 2023, RZV is ...
Characterisation and Hazard identification of substandard and Falsified Antimicrobial Drugs. The CantiBio project 2016-2020
antibiotics Quality risk analysis Abstract: Studies on SF antimicrobials, one of the most frequently used medical products, circulating in Europe or other industrialized regions are very scarce. However, case ...
The strategic change of the API fingerprint programme: from verification of authenticity of API sources to identifying potential quality issues
the Ph. Eur. Monographs with fingerprint studies. Though the latter would be focused on deviating samples and manufacturers, where an inconsistent batch reproducibility could be observed. Pattern ...
Belgian National Burden of Disease Study. Patterns of tobacco use and sales in Belgium: a critical appraisal of available data sources
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Sarah Nayani; Leonor Guariguata; Brecht Devleesschauwer Source: Sciensano, Brussels, Belgium, p.30 (2024) Accession Number: D/2023.14.440/81 Keywords: burden of dise ...
be.Prepared to increase Belgian integration of health data as a way of strengthening preparedness for infectious diseases
diseases The initial microbial study cases are Listeria, Mycobacterium tuberculosis, Neisseria meningitidis, Salmonella, Influenza and SARS-CoV-2. Here, we present an overview of the components of the be ...
Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
Disease virus (NDV)) fusion protein (F) as an rHVT- H9-F vaccine, is an alternative to currently used classical vaccines. This study investigated H9- and ND-specific humoral and mucosal responses, ...
Magnitude and determinants of excess total, age-specific and sex-specific all-cause mortality in 24 countries worldwide during 2020 and 2021: results on the impact of the COVID-19 pandemic from the C-MOR project.
mortality in 2020 and 2021, respectively. CONCLUSION: This study provides evidence of substantial excess mortality in most countries investigated during the first 2 years of the pandemic and suggests that ...
A One-Health approach to monitoring antimicrobial consumption in Belgium 2012-2021
(AMR), necessitating a unified “One Health” approach to combat this global threat. Shared metrics enhance intersectoral comparisons and coordination. This study compares AMC in the Belgian human (hospital ...
EBoD-FL. Guidelines for mapping the environmental burden of disease in Flanders, 2023
risks. Environmental burden of disease (EBD) studies try to estimate the impact of environmental stressors in terms mortality or morbidity on a population level. Although environmental risks have been ...
Challenges in Chlamydial Serology: Insights from a Belgian and a Dutch Population Cohort.
serology is invaluable. Multiple studies, nonetheless, indicate deficiencies in specificity and sensitivity of current chlamydial antibody detection assays. Incorporation of multiple antigens per target is ...